KIN cancer, the most frequent human neoplasm, occurs in the head and neck in 90% of cases. In this study two forms of nonmelanotic skin cancer were considered: BCC and the more aggressive SCC. Typically, these tumors are only malignant locally. In fact, nodal diffusion only occurs in 3 to 5% of cases and distal metastases are unusual; complete surgical removal is generally curative. 23 The UICC provided the TNM classification system of skin cancer 5, 34 (Table 1 ). In this article we present a series of patients afflicted with BCC or SCC, each of whom had undergone several previous operations. At the time of admission to our department these patients had advanced-stage RSC of the head, with an extensive involvement of the skull base. Recurrent skin cancer of the head in the advanced stage is an uncommon but severe disease, which until recently represented a disappointing therapeutic challenge; most patients were treated by futile local dressings and waited for impending death. 17, 26, 29 Advances in surgical approaches now allow resection of most skull base tumors, which a few years ago would only have received palliative treatment. In particular, pterional craniotomy combined with orbitozygomatic osteotomy, and asterional craniotomy with retrolabyrinthine petrosectomy are standardized surgical procedures that safely allow resection of the involved skull base. 1, 2, 4 Treatment of RSC of the head in the advanced stage is associated with the usual problems of skull base surgery (obliteration of complex dead spaces, preservation of the orbit and middle ear, protection of neurovascular structures, and CSF containment) and also the specific problem of reconstitution of a safe and immunocompetent skin closure to protect the intracranial space. 20 The reconstructive step is a significant part of the operative procedure. In fact, radical excision of an RSC of the head in the advanced stage causes a wide superficial defect because the disease deeply involves the soft tissue and bone of the skull base. In this case, simple mobilization and rotation of regional tissue is not sufficient, but the use of muscular or myocutaneous free flaps allows the transfer of an unlimited amount of wellvascularized distant tissue to fill the excision site.
vide an immunocompetent superficial layer that is also resistant to radiotherapy.
Clinical Material and Methods
Between September 1995 and February 2000, 18 consecutive patients who had RSC of the head in the advanced stage, which invaded either the anterolateral or posterolateral skull base, were surgically treated at our institution. These patients represented 0.9% of all cases treated at our two reference centers for skin diseases. The patients included 16 men and two women ranging in age from 56 to 77 years (mean 73.5 years). The follow-up period in this study ranged from 3 to 53 months (mean 25 months).
Clinical charts, operative reports, neuroimaging studies, and pathological specimens obtained in each patient were reviewed. The area of bone involved by tumor was assessed using CT scanning. Soft-tissue involvement, infiltration of the dura mater or periorbital area, and invasion of the brain were estimated on MR images (Fig. 1) . After surgery, a CT scan was obtained within 1 week and MR images after 1 month.
For the histological diagnosis, skin specimens were placed in a correct geometric orientation and an accurate study of the margins of the resection was performed. Soft tissues, bone, dura, brain, and lymph nodes were analyzed. These data were used to apply the TNM classification in accordance with the UICC staging system. 5, 34 All patients had T4 tumors (Table 2) and a large postablative defect that precluded the use of pedicled or local flaps and required the use of free flaps.
No finding of tumor on postoperative neuroimages and during the histological evaluation led to the determination of no residual disease (Fig. 2) . A diagnosis of minimal residual disease was based on the histological determination of tumor at the margins of the resected tissues together with no evidence of tumor on postoperative neuroimages. Consistent residual disease was defined as a postoperative residual tumor greater than 30% of the original lesion. Postoperative radiotherapy was prescribed in cases in which there was minimal residual disease (six patients) or in cases with a delayed tumor recurrence (four patients). No radiotherapy was performed in four cases in which there was no residual disease and in four cases in which there was consistent residual disease (two patients refused radiotherapy and two died before it could be initiated) ( Table 2) .
Operative Procedure
Neurosurgeons performed tumor resection, dural repair, and bone reconstruction. Plastic surgeons transplanted the harvested muscular or myocutaneous free flap.
After excision of the soft-tissue neoplasm, the following neurosurgical procedures were performed: 1) asterional craniotomy and retrolabyrinthine petrosectomy for an auricular, retroauricular, or mastoid lesion; and 2) pterional craniotomy and orbitozygomatic osteotomy for a temporal fossa, periorbital, or frontoorbital tumor. The extent of bone resection was tailored according to the oncological requirement and infiltrated dura mater was removed.
A pericranial graft or lyophilized dura mater was used for the dural repair and for closing intracranial-sinus communications. Fat tissue and fibrin glue were applied epidurally to prevent a CSF leak and to obliterate any large dead extradural space to minimize air or fluid accumulation. Bone reconstruction was performed using titanium miniplates which were fixed with methyl methacrylate.
The soft-tissue defect was repaired using muscular (five patients) or myocutaneous (13 patients) free flaps. The muscular flaps were grafted using split-thickness skin grafts.
Preoperatively Doppler ultrasonography was performed to select the vessels of the neck that were most appropriate for anastomosis; postoperatively, it provided a daily assessment of the free-flap viability and monitoring of the vascular patency after radiotherapy.
Statistical Analysis
Survival estimates were generated using the KaplanMeier product-limit method. Survival times were measured from the date of surgery to the date of death (or to the date of the last follow up of surviving patients). The log-rank test was used to compare the distribution of survival times in a univariate analysis and to select statistically significant factors. A multivariate analysis was performed using the Cox proportional hazard model (stepwise selection: enter limit at p Ͻ 0.1, remove limit at p Ͼ 0.15). Relative risks were expressed as the ratio of the relative death rate between two groups (observed/expected). A probability value lower than 0.05 was considered statistically significant.
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Results
The neurosurgery portion of the procedure lasted between 2.5 and 5 hours (mean 3.55 hours) and the plastic surgery portion between 7 and 11 hours (mean 8.5 hours). Asterional craniotomy and retrolabyrinthine petrosectomy were performed in six patients (33.3%) and pterional craniotomy and orbitozygomatic osteotomy in 12 patients (66.7%).
In one patient brain parenchyma was resected because of tumor infiltration (Fig. 3) . Total parotidectomy was necessary in two patients (11.1%) and dural repair was necessary in five (27.8%). Cranioplasty was performed in 14 patients (77.8%); in the four patients (22.2%) with consistent residual disease, bone reconstruction was considered but not indicated. The rectus abdominis muscle was used in three patients (16.7%) and the latissimus dorsi muscle in the remaining 15 (83.3%), according to the volume and depth of the defect and skin surface area requirements. Twelve free flaps (66.7%) were attached to the homolateral temporal artery and vein, five (27.8%) to the homolateral facial vessels, and one (5.6%) to the homolateral lingual artery and internal jugular vein by using a saphenous vein graft in a patient who had undergone previous radiotherapy. Blood replacement was necessary in 11 patients (61.1%) and amounts ranged between 1200 and 4800 ml (mean 1500 ml). The patients' clinical data are summarized in Table 2 .
Overall Survival
The overall survival time is shown in Fig. 4a . The median survival time was 32 months. The lower 95% confidence limit was 23 months.
Extent of Resection
Postoperatively no residual disease, minimal disease, and consistent residual disease were identified in eight (44.4%), six (33.3%), and four (22.2%) patients, respectively ( Table  2 ). All four patients with consistent residual disease had either extensive invasion of the petrous bone, orbital apex, or infratemporal fossa, or involvement of deep neck structures preoperatively (Fig. 5) . These patients had SCC, which is biologically more aggressive than BCC.
In these cases, surgery failed because the deepest part of the tumor was unapproachable. Conversely, tumors larger * AC-RLP = asterional craniotomy-retrolabyrinthine petrosectomy; CRD = consistent residual disease; MRD = minimal residual disease; no RD = no residual disease; PC-OZO = pterional craniotomy-orbitozygomatic osteotomy; RT = radiotherapy. in size but superficially located may be totally resected. Although the median survival time was not reached by the eight patients with no residual disease because they are still alive, for the 10 patients who had either minimal and consistent residual disease this time point was 23 months (95% CI 11-26 months) and this difference is statistically significant (p = 0.0007; Fig. 4b ). Statistical matching between patients with minimal and consistent residual disease was not feasible because of the small number of cases.
Histological Findings
Basal cell carcinoma was found in 10 patients (55.5%) and SCC in eight (44.5%) ( Table 2) . Of the ten patients with BCC, eight in whom no residual disease was found are still alive and two in whom minimal residual disease was diagnosed died after 24 and 32 months. The median survival time, which was not reached by patients with BCC, was 12 months (95% CI 5-26 months) for those with SCC. The 1-, 2-, and 3-year probability of survival was 100, 85.71,
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Skin cancer involving the skull base and 68.57%, respectively, for patients with BCC and 50, 37.5, and 0%, respectively, for those with SCC. This difference was statistically significant (p = 0.0023; Fig. 4c ).
According to the presence of nodal disease, 14 patients (77.8%) were staged N0 and four (22.2%) N1. The 1-, 2-, and 3-year probability of survival rates were 84, 65, and 43%, respectively, for patients with no diseased lymph nodes (N0), and 50, 50, and 0%, respectively, for patients with nodal disease (N1). There was a trend toward a higher survival rate, but the trend had no statistical significance (p = 0.09).
Radiation Therapy
Adjuvant radiotherapy was prescribed in 14 patients, but was fully administered in only 10 (six of 10 patients with BCC and four of eight patients with SCC) because two patients refused this treatment and two died 3 and 5 months after surgery, respectively ( Table 2 ). The median survival time was 32 months (95% CI 26-51 months) for the 10 patients who received radiotherapy and 12 months (95% CI 5-19 months) for the eight patients who did not receive radiotherapy (Fig. 4d) . This difference was statistically significant (p = 0.016).
Multivariate Analysis
The extent of resection, the histological characteristics of the tumor, and the use of radiotherapy, which significantly affected survival, were analyzed using a multivariate model. The extent of resection and the histological characteristics of resected tissue showed the same statistical result, because the eight patients with no residual disease were the same eight of 10 patients with BCC (p = 0.003). The relative risk for patients with residual disease and with SCC was 10.02.
Radiotherapy also proved to be an independent covariate with a probability value of 0.013 and a relative risk of 13.74 for patients who did not receive radiotherapy. Therefore, the three covariates resulted in independent factors, although the prognostic value of radiotherapy was inferior to both the extent of resection and histological findings.
Complications of Surgery
No deaths were due to the surgery. The free flap survived in all patients, although in one case a reexploration for vascular failure was necessary. No case of deep vein thrombosis, cardiac failure, or pulmonary infection was recorded. Postoperative morbidity was reported in five patients (27.8%). Two of these had transient CSF leaks, which were treated by compressive bandages and lumbar drainage. Another three patients experienced facial nerve palsy, which appeared after total parotidectomy in two of them, and after intrapetrous nerve injury in the third (Fig. 6) . As late complications, radionecrosis of the flap developed in one patient at 12 months of follow up and recurrent disease at the margins of the transplanted tissue occurred in two patients at 25 and 47 months of follow up, respectively. Two patients required removal of the acrylic cranioplasty (at 9 and 32 months); this was necessary because of skin erosion in one and tumor recurrence in the other.
Discussion
Recurrent skin cancer of the head in the advanced stage is uncommon, particularly aggressive, and difficult to control, especially when it involves the retroauricular or temporal region. 10, 28, 33 Radical resection of the extensively involved bone is possible, however, and the use of free flaps allows the plastic surgeon to cover wide defects of soft tissue. Thus some of the hazards that attend this kind of surgical procedure and some difficulties encountered from the oncological point of view have been reduced and a socalled "no man's land" has become a stimulating field for both neurosurgeon and plastic surgeon. 11, 24, 25, 27, 30 At present no data exist to assess the patient's response to therapy by length of survival. It is difficult to compare previous series of patients in whom tumor locations or stages vary. 6, 12, 26, 28, 33 In the present series survival data demonstrate a significantly (p = 0.0007) longer survival time for patients with no residual disease. It therefore seems that particular care must be taken in cases in which preoperative studies show an ex- cessive involvement of soft tissue and bone such as an invasion of deep structures that may hinder complete tumor removal. On the other hand, involvement of the brain alone and that of the parotid gland can still be compatible with total tumor excision. Therefore, surgical treatment does not seem advisable for patients affected by T4N1 SCC with extensive invasion of the petrous bone, orbital apex, infratemporal fossa, and deeper structures of the neck. In similar cases, we reported consistent residual disease and a poor prognosis. Specifically, two patients died at 3 and 5 months, respectively, survival times similar to those of untreated patients.
The mean age of the patients in this series (73.5 years) and the clustering of these types of tumors in patients between 65 and 80 years of age is approximately the same as data in other reports. 6, 31 Although combined and prolonged surgery is considered potentially dangerous in elderly patients, in our series no deaths occurred and the postoperative morbidity rate (27.7%) is acceptable. 6 In particular, complications included transient CSF leak in two patients (11.1%) and facial nerve palsy in three patients (16.6%). Two facial nerve lesions were necessary; a box resection of the involved structures was required to treat the cancers. The mean duration of the neurosurgery portion of the operation was 3.5 hours and the relative blood losses were negligible.
The mean duration of the plastic surgery portion of the procedure was considerably longer (8.5 hours) and in 61% of patients blood replacement was required. Nevertheless, no general complications occurred. Reconstruction with free flaps carries the risk of either discovering minimal residual disease at the histological examination or masking an eventual early recurrence. On the other hand, reconstruction with free flaps did not negatively influence the duration of survival, probably because it permits early administration of adjuvant radiotherapy. Similar to other studies, in our series patients with SCC had a lower probability of survival than those with BCC. 16, 26, 29 Resection of a large RSC of the head involving the skull base is associated with a loss of bone and soft tissue with exposure of the dura mater. Bacterial contamination and wound complications may prolong hospitalization, require secondary surgery, and be life threatening, especially if meningitis develops. 12, 36 Life-threatening infections may develop if there is a CSF leak or an incorrect skin closure of the intracranial space. Careful dural repair and adequate obliteration of dead spaces with fat tissue and vascularized galea consistently reduce the risk of a CSF leak, and represent a legacy of skull base surgery. 3, 8, 14, 15, 18, 31 The use of free flaps represents the gold standard for skin closure of the intracranial space after wide resections. The transferred flap and the bulky thickness of the muscle flap together with fat tissue filled the empty spaces. Direct wound healing was achieved in all patients by careful management and adequate dressing during the early postoperative period. The risk that free flaps might mask tumor recurrence is overcome by serial MR imaging, which permits early diagnosis.
Adjuvant radiotherapy was well tolerated by the free flaps and no negative effects on the patency of microvascular anastomoses were observed. In one case treated with a higher dose of radiation, a small area of radionecrosis developed 1 year later and required surgical revision.
In two patients, a delayed removal of the cranioplasty was necessary because of skin erosion; this occurred in one case in which the tumor recurred outside the transferred flap and in another case in which there was incorrect tailoring of the cranioplasty. The choice of whether to use autologous bone or artificial material remains controversial. 7, 21, 35 In our series, however, acrylic cranioplasty (14 patients) was effective, safe, and compatible with the free flaps. Acrylic cranioplasty provides unlimited amount of material for large defects, is easily tailored for complex reconstructions (orbitozygomatic region), and requires no additional surgery to harvest donor materials.
Finally, the T4 stage of the UICC classification, which comprises tumors with any type of extradermal invasion from tumor with little infiltration of soft tissue such as muscles or fat, to tumors infiltrating the dura, brain, and deepseated regions probably needs a revision. In fact, as shown in the present series, a worsening of the prognosis was related to the involvement of deep seated regions, such as the orbit's apex or the infratemporal fossa. 
Conclusions
Recurrent skin cancer of the head in the advanced stage used to be considered an unfortunate disease of elderly patients with disappointing therapeutic implications. Recent advances in skull base surgery and free-flap reconstruction now allow satisfactory treatment in most of these cases. Our data indicate that effective oncological results can be attained with a significant increase in survival and an acceptable rate of operative morbidity. The key lies in achieving no residual disease or minimal residual disease postoperatively; consistent residual disease has a poor prognosis.
